Status:
UNKNOWN
Prospective Registration Study of Totally Laparoscopy Versus Laparoscopy Assisted Colon Cancer Surgery
Lead Sponsor:
The First Hospital of Jilin University
Conditions:
Colon Cancer
Surgery
Eligibility:
All Genders
18-80 years
Brief Summary
This is a comparison of totally laparoscopic and laparoscopic-assisted colon cancer resection, a prospective registration study comparing the safety and benefits of the two operations
Detailed Description
Colorectal cancer is one of the most common malignant tumors in China. With the advancement of medical science and technology, the treatment of colorectal cancer has become more mature, forming a comp...
Eligibility Criteria
Inclusion
- Age: 18-80 years old, male or female;
- Colon cancer (ascending colon, transverse colon, descending colon, sigmoid colon) is diagnosed by histology or cytology;
- The clinical stage is T1-4aN0-2M0; 4 No multiple distant metastases;
- 5\. ECOG score 0-2; 6. Heart, lung, liver, and kidney functions can tolerate surgery; 7. Patients and their families can understand and are willing to participate in this clinical study, and sign an informed consent.
Exclusion
- Past history of malignant colorectal tumors or recent diagnosis combined with other malignant tumors;
- Patients with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. who need emergency surgery;
- Neighboring organs need to be combined with organ resection;
- New adjuvant therapy before surgery;
- ASA grade ≥ grade IV and/or ECOG physical status score\> 2 points;
- Those who have severe liver and kidney function, cardiopulmonary function, blood coagulation dysfunction, or combined with serious underlying diseases that cannot tolerate surgery;
- History of severe mental illness;
- Pregnant or lactating women;
- Patients with other clinical and laboratory conditions considered by the investigator should not participate in the trial.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 30 2023
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT04853784
Start Date
May 1 2021
End Date
May 30 2023
Last Update
April 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jilin University First Hospital
Changchun, Jilin, China, 130021